IL122609A0 - Meiosis regulating compounds - Google Patents

Meiosis regulating compounds

Info

Publication number
IL122609A0
IL122609A0 IL12260996A IL12260996A IL122609A0 IL 122609 A0 IL122609 A0 IL 122609A0 IL 12260996 A IL12260996 A IL 12260996A IL 12260996 A IL12260996 A IL 12260996A IL 122609 A0 IL122609 A0 IL 122609A0
Authority
IL
Israel
Prior art keywords
regulating compounds
meiosis regulating
meiosis
compounds
regulating
Prior art date
Application number
IL12260996A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL122609A0 publication Critical patent/IL122609A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12260996A 1995-06-23 1996-06-21 Meiosis regulating compounds IL122609A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK72895 1995-06-23
DK73095 1995-06-23
DK146195 1995-12-22
PCT/DK1996/000273 WO1997000884A1 (en) 1995-06-23 1996-06-21 Meiosis regulating compounds

Publications (1)

Publication Number Publication Date
IL122609A0 true IL122609A0 (en) 1998-08-16

Family

ID=27220892

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12260996A IL122609A0 (en) 1995-06-23 1996-06-21 Meiosis regulating compounds

Country Status (18)

Country Link
EP (1) EP0857173B1 (pl)
JP (1) JPH11507929A (pl)
KR (1) KR19990028366A (pl)
CN (1) CN1191543A (pl)
AR (1) AR003441A1 (pl)
AT (1) ATE254628T1 (pl)
AU (1) AU718246B2 (pl)
BR (1) BR9608968A (pl)
CA (1) CA2224866A1 (pl)
CZ (1) CZ408097A3 (pl)
DE (1) DE69630802T2 (pl)
HU (1) HUP9900454A3 (pl)
IL (1) IL122609A0 (pl)
NO (1) NO314231B1 (pl)
PL (1) PL185622B1 (pl)
RU (1) RU2182909C2 (pl)
TW (1) TW474943B (pl)
WO (1) WO1997000884A1 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177420B1 (en) 1997-05-16 2001-01-23 Akzo Nobel N.V. 20-aralkyl-5α-pregnane derivatives
US6262282B1 (en) * 1997-06-04 2001-07-17 Akzo Nobel N.V. 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
DK1042353T3 (da) * 1997-12-18 2002-11-04 Akzo Nobel Nv 17-beta-aryl(arylmethyl)oxy(thio)alkylandrostanderivater
KR20010043558A (ko) 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
EP0957108A1 (en) * 1998-05-14 1999-11-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
KR20010053031A (ko) * 1998-06-19 2001-06-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
AU759344B2 (en) 1998-12-11 2003-04-10 Akzo Nobel N.V. 22S-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
AU3118200A (en) * 1998-12-14 2000-07-03 Merck & Co., Inc. Hiv integrase inhibitors
PL350557A1 (en) * 1999-02-10 2002-12-16 Schering Ag Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
KR20010093276A (ko) * 1999-02-24 2001-10-27 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 불임증 치료
JP2002537349A (ja) 1999-02-24 2002-11-05 ノボ ノルディスク アクティーゼルスカブ 不妊症の治療
AU781994B2 (en) 1999-09-16 2005-06-23 Novo Nordisk A/S Composition for IVF
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
FR2898272B1 (fr) * 2006-03-09 2008-07-04 Trophos Sa Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur
CN102258004B (zh) * 2010-05-27 2013-07-17 中国科学院动物研究所 一种体外保存/培养卵母细胞以抑制卵母细胞生发泡破裂的方法
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
HRP20230747T1 (hr) 2011-09-08 2024-01-05 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihova uporaba
SMT201800657T1 (it) 2013-03-13 2019-01-11 Sage Therapeutics Inc Steroidi neuroattivi e loro metodi di utilizzo
PL3639828T3 (pl) 2013-12-24 2022-05-02 Virginia Commonwealth University Zastosowanie utlenowanych siarczanów cholesterolu (ocs) w leczeniu ostrej niewydolności wątroby
WO2015195967A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ
MX382122B (es) 2015-07-06 2025-03-13 Sage Therapeutics Inc Oxiesteroles y metodos de uso de los mismos.
AU2016289965B2 (en) 2015-07-06 2021-09-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
PL3319611T3 (pl) 2015-07-06 2021-07-12 Sage Therapeutics, Inc. Oksysterole i sposoby ich stosowania
EP3436022B1 (en) 2016-04-01 2022-03-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US10752653B2 (en) 2016-05-06 2020-08-25 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
WO2018009867A1 (en) 2016-07-07 2018-01-11 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
EP3494125B1 (en) 2016-08-02 2022-06-22 Virginia Commonwealth University Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
PT3519422T (pt) 2016-09-30 2022-12-05 Sage Therapeutics Inc Oxisteróis substituídos em c7 e métodos como moduladores nmda
DK4105223T3 (da) 2016-10-18 2025-07-07 Sage Therapeutics Inc Oxysteroler og fremgangsmåder til anvendelse deraf
CA3041088C (en) 2016-10-18 2024-05-21 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
CN112430251A (zh) * 2020-11-23 2021-03-02 广州瀚信通信科技股份有限公司 一种治疗白内障的化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols

Also Published As

Publication number Publication date
BR9608968A (pt) 1999-06-29
AU718246B2 (en) 2000-04-13
DE69630802D1 (de) 2003-12-24
WO1997000884A1 (en) 1997-01-09
KR19990028366A (ko) 1999-04-15
ATE254628T1 (de) 2003-12-15
PL185622B1 (pl) 2003-06-30
NO314231B1 (no) 2003-02-17
EP0857173B1 (en) 2003-11-19
HUP9900454A2 (hu) 1999-06-28
DE69630802T2 (de) 2004-08-12
TW474943B (en) 2002-02-01
NO976044D0 (no) 1997-12-22
AR003441A1 (es) 1998-08-05
PL324219A1 (en) 1998-05-11
EP0857173A1 (en) 1998-08-12
CA2224866A1 (en) 1997-01-09
NO976044L (no) 1998-02-20
HUP9900454A3 (en) 1999-11-29
MX9800123A (es) 1998-03-29
CZ408097A3 (cs) 1998-06-17
CN1191543A (zh) 1998-08-26
JPH11507929A (ja) 1999-07-13
AU6122796A (en) 1997-01-22
RU2182909C2 (ru) 2002-05-27

Similar Documents

Publication Publication Date Title
IL122609A0 (en) Meiosis regulating compounds
IL139241A0 (en) Meiosis regulating compounds
ZA9610022B (en) Cycloaza compounds
ZA96836B (en) Osmolyte regulator
HUP9904616A3 (en) Meiosis regulating cholestane-derivatives
GB9508810D0 (en) Compounds
GB9500691D0 (en) Compounds
GB9504910D0 (en) Compounds
GB9504948D0 (en) Compounds
AU6122696A (en) Meiosis regulating compounds
IL140216A0 (en) Meiosis regulating compounds
PL335408A1 (en) Meiosis regulating compounds
GB9502540D0 (en) Compounds
ZA965333B (en) Melosis regulating compounds
PL345039A1 (en) Meiosis regulating compounds
ZA955213B (en) Regulation of meiosis
GB9502785D0 (en) Compounds
GB9504990D0 (en) Compounds
GB9502983D0 (en) Compounds
GB9504190D0 (en) Compounds
GB9502784D0 (en) Compounds
GB9502783D0 (en) Compounds
GB9502782D0 (en) Compounds
GB9504801D0 (en) Compounds
GB9504802D0 (en) Compounds